Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 5,755 | 4,925 | 4,647 | 3,824 | 3,566 |
| Cost of Goods | 1,786 | 1,568 | 1,265 | 1,517 | 1,482 |
| Gross Profit | 3,970 | 3,357 | 3,382 | 2,307 | 2,084 |
| Operating Expenses | 8,943 | 7,026 | 7,452 | 4,973 | 4,897 |
| Operating Income | -4,188 | -3,101 | -3,805 | -2,149 | -2,331 |
| Other Income | -1,633 | 119 | -19 | 95 | 596 |
| Pre-tax Income | -5,821 | -2,982 | -3,824 | -2,054 | -1,735 |
| Net Income Continuous | -5,821 | -2,982 | -3,147 | -2,054 | -1,735 |
| Net Income | $-5,821 | $-2,982 | $-3,147 | $-2,054 | $-1,735 |
| EPS Basic Total Ops | -0.19 | -0.10 | -0.13 | -0.07 | -0.06 |
| EPS Basic Continuous Ops | -0.19 | -0.10 | -0.11 | -0.07 | -0.06 |
| EPS Diluted Total Ops | -0.19 | -0.10 | -0.13 | -0.07 | -0.06 |
| EPS Diluted Continuous Ops | -0.19 | -0.10 | -0.11 | -0.07 | -0.06 |
| EBITDA(a) | $-4,103 | $-3,019 | $-3,723 | $-2,065 | $-2,275 |